GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Moderna Inc (LIM:MRNA) » Definitions » Inventories, Finished Goods

Moderna (LIM:MRNA) Inventories, Finished Goods : $28 Mil (As of Dec. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Moderna Inventories, Finished Goods?

Moderna's quarterly finished goods increased from Jun. 2024 ($34 Mil) to Sep. 2024 ($146 Mil) but then declined from Sep. 2024 ($146 Mil) to Dec. 2024 ($28 Mil).

Moderna's annual finished goods declined from Dec. 2022 ($169 Mil) to Dec. 2023 ($24 Mil) but then increased from Dec. 2023 ($24 Mil) to Dec. 2024 ($28 Mil).

Moderna Inventories, Finished Goods Historical Data

The historical data trend for Moderna's Inventories, Finished Goods can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Moderna Inventories, Finished Goods Chart

Moderna Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Inventories, Finished Goods
Get a 7-Day Free Trial Premium Member Only 1.00 233.00 169.00 24.00 28.00

Moderna Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Inventories, Finished Goods Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 24.00 20.00 34.00 146.00 28.00

Moderna Inventories, Finished Goods Calculation

The products in a manufacturer's inventory that are completed and are waiting to be sold.

Moderna Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Moderna Inc (LIM:MRNA) » Definitions » Inventories, Finished Goods
Comparable Companies
INCY RPRX BMRN EXEL INSM ASND TECH SMMT PCVX HALO VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX ALNY XBRU:UCB ONC XKRX:068270 BNTX
Traded in Other Exchanges
MRNA:USA MRNA:Mexico 1MRNA:Italy 0QFd:UK 0A45:UK 0QF:Germany M1RN34:Brazil 0QF:Bulgaria MRNA:Austria
Address
325 Binney Street, Cambridge, MA, USA, 02139
Website
https://www.modernatx.com
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 40 mRNA development candidates in clinical development as of September 2024. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.